Open access chemical and clinical probes to support drug discovery

被引：0

作者：

Aled M Edwards

Chas Bountra

David J Kerr

Timothy M Willson

机构：

[1] Aled M. Edwards is in the Structural Genomics Consortium,

[2] University of Toronto,undefined

[3] Toronto,undefined

[4] Ontario,undefined

[5] Canada.,undefined

[6] Chas Bountra is in the Structural Genomics Consortium,undefined

[7] University of Oxford,undefined

[8] Headington,undefined

[9] Oxford,undefined

[10] UK.,undefined

[11] David J. Kerr is at the Sidra Medical & Research Center,undefined

[12] Qatar Foundation,undefined

[13] Doha,undefined

[14] Qatar.,undefined

[15] Timothy M. Willson is in Discovery Medicinal Chemistry,undefined

[16] GlaxoSmithKline,undefined

[17] Research Triangle Park,undefined

[18] North Carolina,undefined

[19] USA.,undefined

来源：

Nature Chemical Biology | 2009年 / 5卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.

引用

页码：436 / 440

页数：4

共 50 条

[41] Chemical effectors in drug discovery
Michne, WF
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (04) : 369 - 369
[42] Evolution of an open-access quantitative bioanalytical mass spectrometry service in a drug discovery environment
Wright, Patricia
Chassaing, Christophe
Cussans, Nigel
Gibson, Drew
Green, Caroline
Gleave, Michelle
Jones, Russell
Macrae, Paul
Saunders, Kenneth
BIOMEDICAL CHROMATOGRAPHY, 2006, 20 (6-7) : 585 - 596
[43] Open-access public-private partnerships to enable drug discovery - New approaches
Mueller, Susanne
Weigelt, Johan
IDRUGS, 2010, 13 (03) : 175 - 180
[44] Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space
Alvim-Gaston, Maria
Grese, Timothy
Mahoui, Abdelaziz
Palkowitz, Alan D.
Pineiro-Nunez, Marta
Watson, Ian
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (03) : 294 - 303
[45] A Discovery Hub for Diamond Open Access publishing
Bardi, Alessia
Bargheer, Margo
Manghi, Paolo
CEUR Workshop Proceedings, 2023, 3365 : 162 - 166
[46] Open Source Drug Discovery with Bioclipse
Spjuth, Ola
Carlsson, Lars
Alvarsson, Jonathan
Georgiev, Valentin
Willighagen, Egon
Eklund, Martin
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (18) : 1980 - 1986
[47] An Open Innovation Ecosystem for Drug Discovery
Barnes, Michael R.
MEDCHEMCOMM, 2012, 3 (01) : MCW92 - MCW97
[48] Open access wins German support
Schiermeier, Q
NATURE, 2003, 425 (6960) : 752 - 752
[49] Open source drug discovery for malaria
Todd, M.
Wells, T.
Willis, P.
Olliaro, P.
Avery, V.
Ralph, S.
Gamo, J.
Charman, S.
Ylioja, P.
Robertson, M.
Williamson, A.
Batra, S.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 69 - 69
[50] Disagreement over support for open access
不详
CHEMISTRY WORLD, 2005, 2 (12): : 9 - 9

← 1 2 3 4 5 →